Biosynthesis of Cu <sub>2‐x</sub> Se Nanocatalyst Within Probiotics for Repolarization of Tumor Associated Macrophages to Boost Mild Photothermal Sensitized Chemodynamic Immunotherapy
The activation and infiltration of cytotoxic T lymphocytes (CTLs) are the key of tumor immunotherapy. However, the suppressive tumor immune microenvironment usually inhibits the function of CTLs. Tumor-associated macrophages (TAMs) play an important role in remodeling the tumor immune microenvironment. In this work, probiotic Escherichia coli Nissle 1917 (EcN) is used as a bioreactor to achieve intracellular synthesis of copper selenide nanoparticles (Cu<sub>2-x</sub>Se NPs), giving Cu<sub>2-x</sub>Se@EcN, which effectively repolarize macrophages from pro-tumor M2 phenotype to anti-tumor M1 phenotype mainly through activating MAPK signaling pathway. The synthesized Cu<sub>2-x</sub>Se NPs exhibited excellent photothermal performance, inducing hyperthermia-sensitized Fenton-like reaction to catalyze the generation of hydroxyl radical from H<sub>2</sub>O<sub>2</sub>, then resulted in immunogenic death effect of tumor cells and the repolarization of M2 macrophages. Combined with surface-expressed pathogen-associated molecular patterns (PAMPs) of bacteria, Cu<sub>2-x</sub>Se@EcN synergistically promoted DCs maturation and TAMs reprogramming, eventually promoting the infiltration and activation of T cells. Therefore, the bacteria-inorganic hybrid nanomaterials showed satisfied effect in inhibiting tumor growth and recurrence.
Authors
- Meichan Wu
- Puze Li
- Yong Shen (ORCID: https://orcid.org/0000-0002-2743-9406)
- Yan Liu (ORCID: https://orcid.org/0000-0003-1698-5783)
- Xiangliang Yang
- Guoping Wang
- Cheng Song
- Qingxia Xu
- Xin Xin
- Jun Hu
Institutions
- Henan Cancer Hospital (CN)
- The Eighth Hospital of Xi'an (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Advanced Healthcare Materials
- Published
- 2026-01-04
- DOI
- https://doi.org/10.1002/adhm.202503745
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00